Murphy & Mullick Capital Management Corp Invests $26,000 in Option Care Health, Inc. (NASDAQ:OPCH)

Murphy & Mullick Capital Management Corp purchased a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 1,125 shares of the company’s stock, valued at approximately $26,000.

Several other institutional investors also recently added to or reduced their stakes in OPCH. Cornerstone Investment Partners LLC raised its position in shares of Option Care Health by 3.6% in the fourth quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company’s stock worth $221,000 after buying an additional 333 shares in the last quarter. UMB Bank n.a. grew its stake in shares of Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after buying an additional 346 shares during the last quarter. Assetmark Inc. increased its stake in Option Care Health by 2.0% in the 4th quarter. Assetmark Inc. now owns 24,976 shares of the company’s stock worth $579,000 after purchasing an additional 487 shares during the period. Pacer Advisors Inc. raised its holdings in Option Care Health by 2.2% during the 4th quarter. Pacer Advisors Inc. now owns 25,483 shares of the company’s stock valued at $591,000 after buying an additional 537 shares during the last quarter. Finally, Sheets Smith Wealth Management boosted its holdings in shares of Option Care Health by 2.4% during the fourth quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company’s stock worth $553,000 after purchasing an additional 550 shares during the period. Institutional investors own 98.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on OPCH shares. UBS Group started coverage on Option Care Health in a research note on Thursday, December 5th. They issued a “neutral” rating and a $26.00 target price for the company. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their target price for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Barrington Research raised their price target on Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a research note on Thursday, February 27th. Finally, JMP Securities restated a “market outperform” rating and set a $30.00 target price (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $33.00.

Insider Activity

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the firm’s stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now owns 44,974 shares of the company’s stock, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 0.64% of the company’s stock.

Option Care Health Stock Performance

OPCH stock opened at $34.73 on Friday. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The business has a 50-day moving average price of $32.47 and a 200 day moving average price of $28.44. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The company has a market capitalization of $5.70 billion, a P/E ratio of 29.18, a PEG ratio of 2.30 and a beta of 1.33.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.